Label gives guidance in use when restoring normal heart rhythm
Discount swings NICE decision, drug will compete with GSK rival
This week’s news
Collaboration will develop drugs for inflammatory diseases
New tool will help screen for Long QT syndrome to prevent sudden deaths.
Vosevi is aimed at tough to treat patients.
President may have to work with Democrats to reform healthcare system
The Mayo Clinic’s new startup company uses artificial intelligence to discover novel treatments.
Authors “optimistic” despite issues with front runners from AB Science and Otsuka
New £86 million fund aims to speed up patient access to innovative digital technologies.
Neratinib can be used to reduce risk of disease returning.
Teva accused of “pay for delay” deal with Cephalon.
Luxturna granted six-month priority review by FDA.
Simon Stevens hails success in negotiating with pharma companies on price and data, and has defended NHS England’s record in promoting innovative medicines.
Solution will let patients access, add to and electronically share their medical information.